“However, this observed cardioprotection was significantly attenuated by perfusion of N-nitro L-arginine methyl ester , an eNOS inhibitor (100 μM/L) noted in terms of increase in myocardial infarct size, release of lactate dehydrogenase and creatinine kinase-MB, and also decreases in release of NO.”